Xinkang Biotech Launches Comprehensive Solution for Foot-Spine Centers: Backed by Experience from Over 200 Hospitals, Driving Multidimensional Department Upgrades
From "Proficient Use" to "Mastery"—One-Stop Equipment and Discipline Development Enables Rapid and Replicable Implementation of Foot and Spine Diagnosis and Treatment
Hangzhou, July 28, 2025—Xinkang Biomedical Technology (Hangzhou) Co., Ltd. (hereinafter referred to as "Xinkang Biotech") announced today the official launch of its "Comprehensive Solution for Foot-Spine Center Development," leveraging its extensive experience in deep departmental construction across more than 200 hospitals nationwide. Covering the entire chain of "planning and design—equipment integration—talent cultivation—operational empowerment," this solution has already enabled multiple rehabilitation, orthopedics, pediatrics, and neurology departments to rapidly transition into specialized foot and spine centers, creating new growth opportunities within hospitals.
Challenges in Development: Traditional Departments Face "Four Major Shortcomings"
- Space and Workflow: Lack of streamlined layouts tailored for foot-spine care, resulting in poor patient experience.
- Equipment and Data: Outdated equipment operating in isolation, with slow updates and limited integration with hospital information systems.
- Talent and Techniques: Fragmented treatment pathways, with young doctors and therapists lacking systematic training.
- Academic and Operational Impact: Limited departmental influence, insufficient cross-disciplinary communication, and academic output.
Xinkang Biotech's Solution: Tangible, Effective, and Easy to Use
Top-Level Planning—Delivering a "Foot-Spine Center Blueprint" in Three Days
- Customized functional zoning, workflow design, and investment evaluation based on hospital needs.
- BIM visualization design, enabling hospital leadership to grasp the entire renovation plan at a glance.
Equipment First—Over 1,000 Advanced Biomechanical Devices Available
- More than 30 modular devices, including plantar pressure gait analysis, 3D spine scanning, and dynamic weight-bearing training.
- Seamless integration with HIS/PACS systems for cloud-based data storage and automated report generation.
- Equipment update rate improved by 80% compared to traditional models, with maintenance costs reduced by 35%.
Talent Incubation—"Department-Specific Training Camp" Available Year-Round
- Close-proximity mentorship: Featuring 40+ top domestic experts, with dual approaches of offline workshops and live-streamed classes.
- S.O.P. Course Packages: Covering assessment → diagnosis → rehabilitation → follow-up, helping medical staff replicate successful cases quickly.
- Over 200 specialist doctors and therapists trained, spanning 20 provinces and cities.
Academic & Operational Support—Building "Regional Model Foot-Spine Centers"
- Co-hosted 80 specialized training sessions, enhancing hospitals' academic presence at provincial and municipal levels.
- Collaborative data research: Co-published 15 core journal papers in the foot-spine field with hospitals.
- Patient inflow increased by 25% annually through external consultations and educational short videos.
Real-World Example: Comparison of a Rehabilitation Department Before and After Renovation in a Tertiary Hospital in Hangzhou
- Renovation Period: 45 days
- Space Expansion: Original rehabilitation therapy area of 300 m² → Foot-Spine Center of 340 m² (13% expansion)
- Daily Patient Visits: 32 → 85 (166% increase)
- Unit Diagnosis Revenue: Increased by 2.3 times, with ROI recovery shortened to 14 months
- Staff Satisfaction: With equipment and S.O.P. implementation, the time for young therapists to independently conduct gait analysis reduced from 30 minutes to 8 minutes
Next Steps: Recruiting 30 "Model Co-Development Hospitals"
Xinkang Biotech plans to sign "Foot-Spine Center Model Co-Development Agreements" with 30 hospitals nationwide by the end of 2025. These agreements will provide customized development solutions, joint brand promotion, and research funding support, working together to drive high-quality development in foot-spine diagnosis and treatment.
About Xinkang Biotech
Xinkang Biomedical Technology (Hangzhou) Co., Ltd. is a leading provider of high-end Medical Equipment and discipline development services, integrating research, production, sales, and service. Dedicated to empowering hospital discipline development with "equipment as the foundation, technology as the wings, and service at the core," Xinkang Biotech has participated in the upgrade of over 200 hospital departments as of the first half of 2025, with more than 1,000 devices deployed nationwide.